News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
96,835 Results
Type
Article (5522)
Company Profile (9)
Press Release (91304)
Section
Business (39265)
Career Advice (353)
Deals (7020)
Drug Delivery (17)
Drug Development (8590)
Employer Resources (29)
FDA (1380)
Job Trends (1748)
News (55719)
Policy (3870)
Tag
2024 Biotech Beach Standard (1)
2026 Genetown Elite (1)
Academia (256)
Adcomms (1)
Allergies (9)
Alliances (5297)
ALS (7)
Alzheimer's disease (143)
Antibody-drug conjugate (ADC) (18)
Approvals (1384)
Artificial intelligence (29)
Autoimmune disease (6)
Automation (2)
Bankruptcy (65)
Best Places to Work (1427)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (10)
Bladder cancer (4)
Brain cancer (2)
Breast cancer (40)
Cancer (258)
Cardiovascular disease (8)
Career advice (308)
Career pathing (2)
CAR-T (22)
Cell therapy (68)
Cervical cancer (2)
Clinical research (6908)
Collaboration (114)
Compensation (22)
Complete response letters (3)
COVID-19 (319)
CRISPR (3)
C-suite (78)
Cystic fibrosis (20)
Data (230)
Denatured (2)
Depression (5)
Diabetes (50)
Diagnostics (773)
Digital health (4)
Diversity, equity & inclusion (10)
Drug discovery (24)
Drug pricing (12)
Drug shortages (5)
Duchenne muscular dystrophy (24)
Earnings (16854)
Editorial (11)
Employer branding (1)
Employer resources (27)
Events (10666)
Executive appointments (278)
FDA (1518)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (141)
Gene editing (12)
Gene therapy (40)
GLP-1 (126)
Government (534)
Grass and pollen (1)
Guidances (7)
Healthcare (2917)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (17)
Indications (2)
Infectious disease (340)
Inflammatory bowel disease (33)
Influenza (7)
Intellectual property (21)
Interviews (43)
IPO (3016)
IRA (6)
Job creations (343)
Job search strategy (276)
Kidney cancer (2)
Labor market (7)
Layoffs (56)
Leadership (1)
Legal (1025)
Liver cancer (6)
Lung cancer (25)
Lymphoma (15)
Management (7)
Manufacturing (57)
MASH (16)
Medical device (2051)
Medtech (2052)
Mergers & acquisitions (4143)
Metabolic disorders (107)
Multiple sclerosis (8)
NASH (3)
Neurodegenerative disease (14)
Neuropsychiatric disorders (4)
Neuroscience (205)
NextGen: Class of 2025 (943)
Non-profit (414)
Northern California (388)
Now hiring (3)
Obesity (49)
Opinion (47)
Ovarian cancer (16)
Pain (19)
Pancreatic cancer (6)
Parkinson's disease (15)
Partnered (1)
Patents (36)
Patient recruitment (13)
Peanut (4)
People (16383)
Pharmaceutical (10)
Pharmacy benefit managers (5)
Phase I (2223)
Phase II (3231)
Phase III (2404)
Pipeline (221)
Podcasts (10)
Policy (18)
Postmarket research (158)
Preclinical (803)
Press Release (17)
Prostate cancer (17)
Psychedelics (7)
Radiopharmaceuticals (68)
Rare diseases (54)
Real estate (532)
Recruiting (15)
Regulatory (2607)
Reports (14)
Research institute (285)
Resumes & cover letters (44)
RSV (3)
Schizophrenia (17)
Series A (38)
Series B (11)
Service/supplier (1)
Sickle cell disease (9)
Southern California (301)
Special edition (3)
Spinal muscular atrophy (16)
Sponsored (7)
Startups (538)
State (1)
Stomach cancer (1)
Supply chain (14)
The Weekly (7)
United States (3249)
Vaccines (93)
Venture capitalists (8)
Webinars (5)
Weight loss (35)
Women's health (7)
Worklife (2)
Date
Today (46)
Last 7 days (130)
Last 30 days (469)
Last 365 days (5757)
2025 (1364)
2024 (6024)
2023 (6532)
2022 (9030)
2021 (9218)
2020 (8312)
2019 (6456)
2018 (5074)
2017 (4764)
2016 (4457)
2015 (5160)
2014 (3857)
2013 (2926)
2012 (3167)
2011 (3312)
2010 (2972)
Location
Africa (104)
Alabama (6)
Alaska (2)
Arizona (31)
Arkansas (4)
Asia (6532)
Australia (944)
California (827)
Canada (405)
China (75)
Colorado (74)
Connecticut (43)
Delaware (18)
Europe (13645)
Florida (134)
Georgia (35)
Idaho (4)
Illinois (71)
India (2)
Indiana (70)
Japan (21)
Kansas (9)
Kentucky (2)
Maine (5)
Maryland (166)
Massachusetts (529)
Michigan (18)
Minnesota (39)
Missouri (7)
Montana (13)
Nebraska (6)
Nevada (10)
New Hampshire (15)
New Jersey (396)
New Mexico (7)
New York (210)
North Carolina (172)
Northern California (388)
Ohio (38)
Oklahoma (3)
Oregon (2)
Pennsylvania (167)
Puerto Rico (3)
Rhode Island (3)
South America (172)
Southern California (301)
Tennessee (10)
Texas (144)
Utah (28)
Virginia (12)
Washington D.C. (7)
Washington State (39)
West Virginia (1)
Wisconsin (3)
96,835 Results for "lantheus holdings".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism
SonoVascular, Inc. has executed an exclusive clinical supply agreement with Lantheus Holdings, Inc. to use Lantheus’ microbubbles in combination with SonoVascular’s SonoThrombectomy System to treat deep vein thrombosis and pulmonary embolism.
May 2, 2024
·
5 min read
Press Releases
CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment
March 27, 2025
·
3 min read
Business
Lantheus Announces Executive Appointments to Accelerate Innovation - May 15, 2024
Lantheus Holdings, Inc. announced Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer and Jean-Claude Provost, MD has been named Chief Science Officer, effective May 28, 2024.
May 15, 2024
·
4 min read
Press Releases
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
January 28, 2025
·
9 min read
Press Releases
Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
December 30, 2024
·
2 min read
Drug Development
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Lantheus Holdings, Inc. today announced statistically significant topline results from the pivotal phase 3 SPLASH study evaluating the efficacy and safety of 177 Lu-PNT2002, a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT).
December 18, 2023
·
10 min read
Business
POINT Biopharma Announces Closing of Agreements with Lantheus Holdings
POINT Biopharma Global Inc. (“POINT”) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance, have been met for the previously announced agreements with Lantheus Holdings Inc. (NASDAQ: LNTH).
December 20, 2022
·
5 min read
Radiopharm Receives Strategic Investment for up to A$18 million
Radiopharm Theranostics Limited, a developer of diagnostic and therapeutic radiopharmaceutical products, has entered into strategic agreements with Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company, and its affiliates.
June 20, 2024
·
6 min read
Press Releases
Genflow Biosciences PLC Announces Holding(s) in Company - 2
January 13, 2025
·
2 min read
Drug Development
Point and Lantheus’s Radioligand Drug Shows Effectiveness, but Not Enough for Wall Street
While the candidate was effective in Phase III results, Point’s stock price fell following the announcement.
December 18, 2023
·
2 min read
·
Tyler Patchen
1 of 9,684
Next